170 related articles for article (PubMed ID: 30344671)
1. Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer's disease.
Gu QF; Yu JZ; Wu H; Li YH; Liu CY; Feng L; Zhang GX; Xiao BG; Ma CG
Exp Ther Med; 2018 Nov; 16(5):3929-3938. PubMed ID: 30344671
[TBL] [Abstract][Full Text] [Related]
2. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG
Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
[TBL] [Abstract][Full Text] [Related]
4. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
6. FSD-C10 Shows Therapeutic Effects in Suppressing oxidized low-density lipoprotein (ox-LDL)-Induced Human Brain Microvascular Endothelial Cells Apoptosis via Rho-Associated Coiled-Coil Kinase (ROCK)/Mitogen-Activated Protein Kinase (MAPK) Signaling.
Wang X; Mao R; Chen W
Med Sci Monit; 2018 Aug; 24():5509-5516. PubMed ID: 30088495
[TBL] [Abstract][Full Text] [Related]
7. Epicatechin Plus Treadmill Exercise are Neuroprotective Against Moderate-stage Amyloid Precursor Protein/Presenilin 1 Mice.
Zhang Z; Wu H; Huang H
Pharmacogn Mag; 2016 May; 12(Suppl 2):S139-46. PubMed ID: 27279698
[TBL] [Abstract][Full Text] [Related]
8. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
10. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
11. FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms.
Li YH; Xie C; Zhang Y; Li X; Zhang HF; Wang Q; Chai Z; Xiao BG; Thome R; Zhang GX; Ma CG
Sci Rep; 2017 Jan; 7():41227. PubMed ID: 28112256
[TBL] [Abstract][Full Text] [Related]
12. The Rho kinase inhibitor fasudil attenuates Aβ
Gao Y; Yan Y; Fang Q; Zhang N; Kumar G; Zhang J; Song LJ; Yu J; Zhao L; Zhang HT; Ma CG
Metab Brain Dis; 2019 Dec; 34(6):1787-1801. PubMed ID: 31482248
[TBL] [Abstract][Full Text] [Related]
13. [Effect of electroacupuncture on recognition memory and levels of Aβ, inflammatory factor proteins and aquaporin 4 in hippocampus of APP/PS1 double transgenic mice].
Wang LM; Zhao TT; Zhou HP; Zhou ZY; Huang S; Ling YL; Shao SJ
Zhen Ci Yan Jiu; 2020 Jun; 45(6):431-7. PubMed ID: 32643878
[TBL] [Abstract][Full Text] [Related]
14. [Moxibustion improves learning-memory ability by promoting cellular autophagy and regulating autophagy-related proteins in hippocampus and cerebral cortex in APP/PS1 transgenic Alzheimer's disease mice].
Zhu CF; Zhang LD; Song XG; Yang J; Pan HP; He CG; Yang K; Qin XF; Zhu WL
Zhen Ci Yan Jiu; 2019 Apr; 44(4):235-41. PubMed ID: 31056874
[TBL] [Abstract][Full Text] [Related]
15. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
16. [Fasudil improves cognition of APP/PS1 transgenic mice via inhibiting the activation of microglia and shifting microglia phenotypes from M1 to M2].
Yu J; Gu Q; Yan Y; Yu H; Guo M; Liu C; Song G; Chai Z; Wang Q; Xiao B; Zhang H; Jiang Y; Ma C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1585-1593. PubMed ID: 29382415
[TBL] [Abstract][Full Text] [Related]
17. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
18. Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer's Disease-Related Changes Through the Regulation of the Peripheral Immune System.
Yu J; Yan Y; Gu Q; Kumar G; Yu H; Zhao Y; Liu C; Gao Y; Chai Z; Chumber J; Xiao BG; Zhang GX; Zhang HT; Jiang Y; Ma CG
Front Aging Neurosci; 2018; 10():216. PubMed ID: 30061826
[TBL] [Abstract][Full Text] [Related]
19. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
20. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
